Belgium Pharmaceutical Market Share

Statistics for the 2023 & 2024 Belgium Pharmaceutical market share, created by Mordor Intelligence™ Industry Reports. Belgium Pharmaceutical share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Belgium Pharmaceutical Industry

The Belgium pharmaceutical market is highly competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some prominent players are vigorously making acquisitions and joint ventures with other companies to consolidate their market positions in the country. Some of the key companies currently dominating the market are AbbVie Inc., AstraZeneca PLC, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, and GlaxoSmithKline PLC, among others.

Belgium Pharmaceutical Market Leaders

  1. C.H. Boehringer Sohn AG & Ko. KG

  2. AstraZeneca plc

  3. AbbVie Inc.

  4. Bayer AG

  5. GlaxoSmithKline plc

*Disclaimer: Major Players sorted in no particular order

AbbVie Inc.,  AstraZeneca PLC, Bayer AG, C.H. Boehringer Sohn AG & Ko. KG, GlaxoSmithKline PLC, F. Hoffmann-La Roche AG, Bristol Myers Squibb Company

Pharma Market in Belgium Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)